Market Overview

Morgan Stanley Remains Confident in Monster Beverage Following Solid Underlying Results

Related MNST
Earnings Scheduled For May 4, 2017
Here's Why Monster Has Little Upside Going Into Earnings
The Vetr community has downgraded $MNST to 4-Stars (Vetr)

In a report published Friday, Morgan Stanley analyst Dara Mohsenian reiterated an Overweight rating and $78.00 price target on Monster Beverage (NASDAQ: MNST).

In the report, Morgan Stanley noted, “MNST Q4 adj. EPS of $0.44 was below cons. ($0.46) and MS ($0.47), however the underlying quality was strong with a +3.2% operating profit beat (or +7.8% beat ex inventory write-offs). Q4 sales were robust, coming in +2.2% above consensus and +0.8% vs. MS (although a $3M load-in in France flattered sales by 60 bps), with gross sales accelerating sequentially in both the US (+12.4%) and International (+19.7%).

"Gross margins were weak, with results -164 bps below consensus (although impacted by a $6M headwind or 110 bps from inventory damages and reserves), but was more than offset by -188 bps of lower than expected operating expenses (with selling & distribution expense 170 bps below MS est.), driving a 3.2% profit beat. Below the line items detracted 5 cents from EPS, with 4 cents from a higher tax rate. We are raising our FY14 EPS by ~1.5% following Q4 results.”

Monster Beverage closed on Thursday at $71.16

Latest Ratings for MNST

Mar 2017JP MorganInitiates Coverage OnOverweight
Dec 2016JefferiesUpgradesHoldBuy
Sep 2016Credit SuisseInitiates Coverage onOutperform

View More Analyst Ratings for MNST
View the Latest Analyst Ratings

Posted-In: Dara Mohsenian Morgan StanleyAnalyst Color Reiteration Analyst Ratings


Related Articles (MNST)

View Comments and Join the Discussion!